Metaphit prevents locomotor activation induced by various psychostimulants and interferes with the dopaminergic system in mice.
Metaphit, an isothiocyanate analog of phencyclidine and a proposed phencyclidine receptor acylator, inactivated the carrier involved in the neuronal uptake of dopamine in in vitro experiments with preparations of the striatum in the mouse. In ex vivo experiments 2 and 24 hr after the intravenous administration of metaphit, no changes were observed either in the binding of [3H]cocaine to striatal membranes or in the uptake of [3H]dopamine into synaptosomes or slices. In in vivo experiments 24 hr after pretreatment with metaphit, selective labelling of uptake sites for dopamine in the striatum of the mouse with [3H]GBR 12935 was unaffected. In these in vivo experiments, however, metaphit antagonized the locomotor stimulation induced by blockers of the uptake of dopamine (methylphenidate, mazindol, cocaine, GBR 12909) but not that induced by drugs that affect locomotion by other mechanisms (amphetamine, phencyclidine). Twenty-four hours after treatment with metaphit there was an increase in homovanillic acid in all regions of the brain studied (striatum, olfactory tubercle, cerebral cortex). There was no effect of metaphit on the disappearance rate of 3,4-dihydroxyphenylacetic acid and homovanillic acid from the striatum during the inhibition of monoamine oxidase with pargyline. If the increase in homovanillic acid reflected a greater rate of dopamine catabolism in metaphit-treated mice, it could explain the lack of locomotor stimulation of blockers uptake of the dopamine in these animals, resulting from a rapid breakdown of extracellularly accumulated dopamine.
Sershen
H
H
Center for Neurochemistry, N.S. Kline Institute for Psychiatric Research, Ward's Island, New York 10035.
Berger
P
P
Jacobson
A E
AE
Rice
K C
KC
Reith
M E
ME
D000661:Amphetamine / Q000037:antagonists & inhibitors*; D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D003042:Cocaine / Q000037:antagonists & inhibitors* / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism / Q000502:physiology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009043:Motor Activity / Q000187:drug effects*; D010622:Phencyclidine / Q000031:analogs & derivatives* / Q000494:pharmacology; D011954:Receptors, Dopamine / Q000187:drug effects
D001679:Biogenic Amines; D011954:Receptors, Dopamine; C044705:metaphit; D000661:Amphetamine; D003042:Cocaine; D010622:Phencyclidine; D004298:Dopamine